Unknown immune molecular targets

The term 'Unknown immune molecular targets' is a non-specific placeholder and does not refer to a distinct, identifiable therapeutic target. In pharmacology and drug discovery, a valid target must be a discrete molecular entity, such as a receptor, enzyme, or ion channel, that plays a functional role in a disease process and can be modulated by a therapeutic agent (Overington et al., 2006, Nature Reviews Drug Discovery). This entry lacks the necessary specificity to identify a particular protein, gene, or signaling pathway. Because it does not represent a specific biological molecule, it cannot be associated with defined molecular classifications, biological functions, or disease roles. Furthermore, it is impossible to determine interacting drugs, mechanisms of action, or safety profiles for an undefined entity. Consequently, this entry is classified as incorrect and unsuitable for structured pharmacological annotation or biotech analysis (Santos et al., 2017, Nature Reviews Drug Discovery).

Not applicable